ICYMI: A highly productive day flying AusBiotech and Medicines Australia’s Cell and Gene Catalyst flag in beautiful Sydney. 👇🏾
#AusCatalyst
#AusCatalyst
June 12, 2025 at 4:15 PM
ICYMI: A highly productive day flying AusBiotech and Medicines Australia’s Cell and Gene Catalyst flag in beautiful Sydney. 👇🏾
#AusCatalyst
#AusCatalyst
Courageous conversations were had in Canberra this week.
It was excellent to be in the room for the National Biotech Medtech Development Summit co-hosted by #AusBiotech and #MTPConnect.
All ideas were on the table during this dynamic national conversation.
It was excellent to be in the room for the National Biotech Medtech Development Summit co-hosted by #AusBiotech and #MTPConnect.
All ideas were on the table during this dynamic national conversation.
November 20, 2024 at 8:53 AM
Courageous conversations were had in Canberra this week.
It was excellent to be in the room for the National Biotech Medtech Development Summit co-hosted by #AusBiotech and #MTPConnect.
All ideas were on the table during this dynamic national conversation.
It was excellent to be in the room for the National Biotech Medtech Development Summit co-hosted by #AusBiotech and #MTPConnect.
All ideas were on the table during this dynamic national conversation.
One week to go until AusBiotech 2025 in Melbourne, Australia. Our team will be on hand to discuss clinical development and site solutions. Visit us at booth 31 or schedule some time to connect.
https://www.fortrea.com/insights/events/ausbiotech
#AusBiotech2025 #AB25 #ClinicalResearch #Fortrea
https://www.fortrea.com/insights/events/ausbiotech
#AusBiotech2025 #AB25 #ClinicalResearch #Fortrea
October 13, 2025 at 10:00 PM
One week to go until AusBiotech 2025 in Melbourne, Australia. Our team will be on hand to discuss clinical development and site solutions. Visit us at booth 31 or schedule some time to connect.
https://www.fortrea.com/insights/events/ausbiotech
#AusBiotech2025 #AB25 #ClinicalResearch #Fortrea
https://www.fortrea.com/insights/events/ausbiotech
#AusBiotech2025 #AB25 #ClinicalResearch #Fortrea
🇦🇺 biotechnology sector with 540 businesses employing 16,310 staff. Within this broader sector, AusBiotech estimates around 300 biotech companies, those focused on oncology and other areas. F6S identifies 54 top biotech companies, and many of these are involved in oncology R&D source Google
April 19, 2025 at 12:08 AM
🇦🇺 biotechnology sector with 540 businesses employing 16,310 staff. Within this broader sector, AusBiotech estimates around 300 biotech companies, those focused on oncology and other areas. F6S identifies 54 top biotech companies, and many of these are involved in oncology R&D source Google
Join us at #AusBiotech2025, booth 31, to collaborate with clinical research professionals, exchange ideas, and discover how Fortrea’s tailored solutions can help enhance clinical trial efficiency and improve patient outcomes.
https://www.fortrea.com/insights/events/ausbiotech
#ClinicalResearch
https://www.fortrea.com/insights/events/ausbiotech
#ClinicalResearch
October 22, 2025 at 10:00 PM
Join us at #AusBiotech2025, booth 31, to collaborate with clinical research professionals, exchange ideas, and discover how Fortrea’s tailored solutions can help enhance clinical trial efficiency and improve patient outcomes.
https://www.fortrea.com/insights/events/ausbiotech
#ClinicalResearch
https://www.fortrea.com/insights/events/ausbiotech
#ClinicalResearch
Cell & gene therapies (CGT) are revolutionising healthcare globally.
Australia’s Cell & Gene Catalyst is accelerating this industry & we have covered a lot of ground!
Read the Catalyst 2024 Impact Report: lnkd.in/gaUC9SFM
Cheers to the peak bodies, industry partners & all involved.
#AusCatalyst
Australia’s Cell & Gene Catalyst is accelerating this industry & we have covered a lot of ground!
Read the Catalyst 2024 Impact Report: lnkd.in/gaUC9SFM
Cheers to the peak bodies, industry partners & all involved.
#AusCatalyst
December 27, 2024 at 2:21 AM
Cell & gene therapies (CGT) are revolutionising healthcare globally.
Australia’s Cell & Gene Catalyst is accelerating this industry & we have covered a lot of ground!
Read the Catalyst 2024 Impact Report: lnkd.in/gaUC9SFM
Cheers to the peak bodies, industry partners & all involved.
#AusCatalyst
Australia’s Cell & Gene Catalyst is accelerating this industry & we have covered a lot of ground!
Read the Catalyst 2024 Impact Report: lnkd.in/gaUC9SFM
Cheers to the peak bodies, industry partners & all involved.
#AusCatalyst
#AusBiotech kicked off with an enlightening session on curating #Bioprecincts and the essentiality of a good coffee shop! Today marks the official start of this inspiring global meeting. Finding out where #AdelaideBioMedCity research & workforce training fit into our national #biomedtech capability.
October 22, 2025 at 12:20 AM
#AusBiotech kicked off with an enlightening session on curating #Bioprecincts and the essentiality of a good coffee shop! Today marks the official start of this inspiring global meeting. Finding out where #AdelaideBioMedCity research & workforce training fit into our national #biomedtech capability.
Australian update: STA and AusBiotech lobby to have RDTI offset extended beyond current 10-year limit: www.linkedin.com/pulse/global...
Global insights to shaping the future of R&D: Your update on Australia's science and technology landscape
Sometimes the greatest contribution of science is not discovering something new but helping us better understand what has always been here. This was my NAIDOC Week reflection after delivering an Ackno...
www.linkedin.com
July 28, 2026 at 1:21 AM
Australian update: STA and AusBiotech lobby to have RDTI offset extended beyond current 10-year limit: www.linkedin.com/pulse/global...
Dr Evans-Galea joins us from AusBiotech and Medicines Australia, where she led the Cell and Gene Catalyst. Her work has shaped Australia’s advanced therapies sector across workforce development, market access and manufacturing.
ARMI welcomes new Deputy Director, Strategy and Planning - Australian Regenerative Medicine Institute
The Australian Regenerative Medicine Institute (ARMI) is excited to announce the appointment of Dr Marguerite Evans-Galea AM as Deputy Director, Strategy and Planning. A scientist, executive leader and advocate with more than 25 years of experience across research, strategy and national collaboration, Dr Evans-Galea brings exceptional insight and vision to this newly created role. She […]
bit.ly
July 31, 2025 at 4:27 AM
Dr Evans-Galea joins us from AusBiotech and Medicines Australia, where she led the Cell and Gene Catalyst. Her work has shaped Australia’s advanced therapies sector across workforce development, market access and manufacturing.
Australia’s cell and gene ecosystem has spoken. Australia’s Cell & Gene Catalyst Pre-Budget Submission 2025-26 calls for:
🔹 The development of access and regulatory pathways that drive faster and broader patient access to cell and gene therapies in Australia.
#AusCatalyst
🔹 The development of access and regulatory pathways that drive faster and broader patient access to cell and gene therapies in Australia.
#AusCatalyst
February 15, 2025 at 1:08 AM
Australia’s cell and gene ecosystem has spoken. Australia’s Cell & Gene Catalyst Pre-Budget Submission 2025-26 calls for:
🔹 The development of access and regulatory pathways that drive faster and broader patient access to cell and gene therapies in Australia.
#AusCatalyst
🔹 The development of access and regulatory pathways that drive faster and broader patient access to cell and gene therapies in Australia.
#AusCatalyst
Australia’s Cell & Gene Catalyst, a joint venture of AusBiotech and Medicines Australia, is partnering with Deloitte to explore the future potential of Australia’s cell and gene ecosystem.
You can participate - do the Investment in Innovation survey: lnkd.in/gF7d5Vm4. Closes Dec 20.
#AusCatalyst
You can participate - do the Investment in Innovation survey: lnkd.in/gF7d5Vm4. Closes Dec 20.
#AusCatalyst
November 27, 2024 at 2:41 PM
Australia’s Cell & Gene Catalyst, a joint venture of AusBiotech and Medicines Australia, is partnering with Deloitte to explore the future potential of Australia’s cell and gene ecosystem.
You can participate - do the Investment in Innovation survey: lnkd.in/gF7d5Vm4. Closes Dec 20.
#AusCatalyst
You can participate - do the Investment in Innovation survey: lnkd.in/gF7d5Vm4. Closes Dec 20.
#AusCatalyst
High value opportunities were also identified, including innovative, advanced therapies such as cell and gene therapies.
It’s an exciting time to be in biotech and medtech folks! Congrats Rebekah Cassidy and Stuart Dignam and all involved.
#AusBiotech #MTPConnect
It’s an exciting time to be in biotech and medtech folks! Congrats Rebekah Cassidy and Stuart Dignam and all involved.
#AusBiotech #MTPConnect
November 20, 2024 at 8:53 AM
High value opportunities were also identified, including innovative, advanced therapies such as cell and gene therapies.
It’s an exciting time to be in biotech and medtech folks! Congrats Rebekah Cassidy and Stuart Dignam and all involved.
#AusBiotech #MTPConnect
It’s an exciting time to be in biotech and medtech folks! Congrats Rebekah Cassidy and Stuart Dignam and all involved.
#AusBiotech #MTPConnect
Areas discussed included enabling and scaling commercialisation, market access, regulatory pathways, manufacturing, procurement, investment, raising capital, horizon-scanning, workforce development, collaboration, knowledge-sharing, infrastructure, clinical trials and more. #AusBiotech #MTPConnect
November 20, 2024 at 8:53 AM
Areas discussed included enabling and scaling commercialisation, market access, regulatory pathways, manufacturing, procurement, investment, raising capital, horizon-scanning, workforce development, collaboration, knowledge-sharing, infrastructure, clinical trials and more. #AusBiotech #MTPConnect
Choosing the right #MIDD approach is key, says @CarlkRx from @MonashPharm - determine what questions need to be answered and design the correct study #BiotechTalks @AusBiotech
March 5, 2026 at 10:59 PM
Choosing the right #MIDD approach is key, says @CarlkRx from @MonashPharm - determine what questions need to be answered and design the correct study #BiotechTalks @AusBiotech
Thanks @AndMacUSyd - great 101 session on physiologically-based pharmacokinetic (#PBPK) modelling - "putting the person back into personalised medicine" #BiotechTalks @AusBiotech
March 5, 2026 at 10:59 PM
Thanks @AndMacUSyd - great 101 session on physiologically-based pharmacokinetic (#PBPK) modelling - "putting the person back into personalised medicine" #BiotechTalks @AusBiotech
Very interesting #BiotechTalk this morning on model-informed drug development (#MIDD) hosted by @AusBiotech with speakers from @Certara @MonashPharm & @Sydney_Uni
March 5, 2026 at 10:59 PM
Very interesting #BiotechTalk this morning on model-informed drug development (#MIDD) hosted by @AusBiotech with speakers from @Certara @MonashPharm & @Sydney_Uni
Just registered for @AusBiotech 2021 at https://www.ausbiotechnc.org/
February 13, 2025 at 2:39 AM
Just registered for @AusBiotech 2021 at https://www.ausbiotechnc.org/
CGT & PROPOSED RDTI CHANGES CREATING UNCERTAINTY IN LIFE SCIENCES Mixed messaging from Government recognising 10 year plus timeframes to take product to market, With Rebekah Cassidy CEO, AusBiotech & Professor Michael Valenzuela, Founder and Chief Scientific Officer, Skin2Neuron youtu.be/T55COOYuuCs
June 19, 2026 at 12:50 AM
CGT & PROPOSED RDTI CHANGES CREATING UNCERTAINTY IN LIFE SCIENCES Mixed messaging from Government recognising 10 year plus timeframes to take product to market, With Rebekah Cassidy CEO, AusBiotech & Professor Michael Valenzuela, Founder and Chief Scientific Officer, Skin2Neuron youtu.be/T55COOYuuCs